A Dnmt3b é a principal DNA metiltransferase no processo de remetilação de regiões de DNA repetitivo do genoma durante a onda de reprogramação epigenética que ocorre no desenvolvimento embrionário. Sua expressão é regulada por uma série de mecanismos, entre os quais encontram-se os microRNAs (miRNAs). O objetivo deste trabalho foi investigar o papel dos mRNAs hsa-miR-203, hsa-miR-26a e hsa-miR-26b na regulação da expressão de DNMT3B durante a diferenciação de células-tronco embrionárias humanas e suas consequências para a metilação do DNA destas células. Para isto, geramos curvas de expressão dos miRNAs investigados, bem como da DNMT3B, a fim de verificar a existência de correlação entre elas. Também analisamos o efeito da superexpressão de miRNAs miméticos sobre a expressão de DMMT3B e o efeito da inibição da interação entre os miRNAs e a região 3\'UTR de DNMT3B sobre a expressão da DNA metiltransferase e sobre os níveis de metilação do DNA das células. Constatamos que a expressão de DNMT3B está inversamente correlacionada com a expressão dos miRNAs hsa-miR-203, hsa-miR-26a e hsa-miR-26b, mas não do hsa-miR-29b, regulador já validado para o controle da expressão de DNMT3B em células tumorais. Verificamos também que o impedimento da ligação do hsa-miR-203 ao segundo sítio predito para a ligação deste miRNA ao mRNA de DNMT3B ocasionou um aumento significativo na expressão da DNA metiltransferase, embora tal aumento não tenha refletido alteração nos níveis de metilação do DNA das células. Desta forma, concluímos que os miRNAs investigados fazem parte da maquinaria de regulação da DNA metiltransferase 3B na diferenciação de células-tronco embrionárias, embora o exato papel funcional de cada um deles no controle da expressão de DNMT3B e na metilação do DNA destas células ainda necessite ser melhor esclarecido / Dnmt3b is the major DNA methyltransferase in the proccess of repetitive DNA remethylation during the epigenetic reprogramming wave that occurs in the embryonic development. Its expression is regulated through several mechanisms, including microRNA (miRNAs). The aim of this study was to investigate the role of the miRNAs hsa-miR-203, hsa-miR-26a, and hsa-miR-26b in the regulation of DNMT3B expression during the differentiation of human embryonic stem-cells, and its consequences to the DNA methylation of these cells. To accomplish this, we generated expression curves for the investigated miRNAs, as well as for DNMT3B, to verify the existence of correlation between them. We also analysed the effect of superexpressing mimetic miRNAs on DNMT3B expression, and the effect of inhibiting the interaction of these miRNAs with DNMT3B 3\'UTR region on the DNA methyltransferase expression and the levels of DNA methyation. We found that DNMT3B expression is inversely correlated to hsa-miR-203, hsa-miR-26a, and hsa-miR-26b expression, but not to hsa-miR-29b, a previously validated DNMT3B regulator in tumor cells. We also verified that blocking the interaction of hsa-miR-203 to its predicted second interaction site at the DNMT3B mRNA significantly increased DNMT3B expression, but did not interfere with the levels of DNA methylation in these cells. Thus, we conclude that the investigated miRNAs are part of the DNMT3B regulatory machinery during the differentiation of embryonic stem-cells, although the exact functional role of each of them in the control of DNMT3B expression and in the DNA methylation of these cells still remains to be further explored

Chromatin remodelling proteins support a variety of cellular functions and utilise the energy from ATP hydrolysis to either reposition or evict nucleosomes. One such protein, Lymphoid specific helicase (LSH), regulates DNA methylation in mammalian cells cooperatively with DNA Methyltransferase 3B (DNMT3B) through binding of the N-terminal domain of LSH. The correct functioning of LSH is essential for heterochromatin formation, with a knockout of LSH causing perinatal lethality or severe developmental abnormalities. There is little biochemical data and no structural data on LSH. Therefore, we aim to determine the structural characteristics and regulatory mechanism of LSH in vitro. LSH was expressed in an optimised insect cell system which increased protein yield 25-fold with greater than 95% purity. LSH is monomeric with increased thermal stability upon ATP or ADP binding. Full length LSH could not be crystallised therefore a core ATPase region of LSH missing the N-terminal domain was identified through limited proteolysis. This also provided evidence the N-terminal domain of LSH is disordered, which was proven through biophysical characterisation of LSH1-176. Expression of the LSH ATPase region was weak and the protein was unstable; suggesting the N-terminal domain of LSH is required for LSH stability. Therefore, complementary structural methods were used to study LSH. Crosslinking mass-spectrometry revealed the N and C termini are in close proximity, suggesting flexible linking regions, which was supported by limited proteolysis experiments. Negative staining Electron Microscopy defined LSH as a tri-lobal and elongated structure which could harbour the ATPase region in the two spherical lobes. 3D modelling of SAXS data obtained of LSH was in agreement with EM data. To understand molecular mechanisms of LSH, functional studies investigating LSH:DNA and LSH:DNMT3B interactions were performed. LSH had a KD for dsDNA of 0.4 μM in solution. LSH does not bind ssDNA nor does it have a greater affinity for methylated dsDNA. LSH was found to bind the dsDNA overhangs of nucleosomes but not to core nucleosomes, suggesting LSH solely interacts with DNA in chromatin and not histones. A stable complex of LSH:DNMT3B could not be achieved in vitro, however, other components for complex formation may have been missing. This study has improved our understanding of LSH structure, biophysical properties and its biochemical interaction with DNA and nucleosomes. This study has laid the foundations for the structural investigations of a LSH:nucleosome and potentially a LSH:DNMT3B complex in vitro to gain a greater understanding of how functional domains of LSH regulates its enzymatic function.

京都大学 / 新制・課程博士 / 博士(医学) / 甲第23415号 / 医博第4760号 / 新制||医||1052(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 武藤 学, 教授 浅野 雅秀, 教授 川口 義弥 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

A metilação do DNA em mamíferos é uma importante modificação epigenética, sendo essencial no silenciamento de DNAs repetitivos, de regiões que sofrem imprinting genômico e no estabelecimento do cromossomo X inativo em fêmeas. Existem 5 tipos de DNA Metiltransferases, tendo a DNMT3B um importante papel na metilação de novo. A MeCP2, por sua vez, é uma proteína capaz de reconhecer sítios de DNA metilados e recrutar proteínas responsáveis pela desacetilação das histonas. Isto provoca alterações na conformação da cromatina, impedindo a transcrição gênica. Alterações nos padrões de expressão de DNMT3B e na metilação do DNA encontradas em diferentes tipos de tumores, e a temporalidade de expressão de Dnmt3b e de Mecp2 durante ondas de desmetilação e de metilação que ocorrem no início do desenvolvimento embrionário, podem auxiliar na identificação de fatores envolvidos no estabelecimento e manutenção do padrão de metilação do DNA, os quais ainda são pouco conhecidos. Por sua vez, uma nova classe de pequenos RNAs, os microRNAs, envolvidos com a regulação da expressão gênica pós-transcricional, têm grande importância na manutenção do estado diferenciado de diferentes tipos celulares. Trabalhos recentes demonstram também que há alterações nos padrões de expressão de microRNAs entre tecidos normais e tumorais. Assim, é objetivo deste trabalho a identificação de possíveis miRNAs envolvidos na modulação da expressão dos genes DNMT3B/Dnmt3b e MeCP2/Mecp2 em diferentes linhagens de células normais e tumorais, bem como, em células tronco embrionárias humanas e murinas submetidas à diferenciação. / DNA methylation in mammals is an important epigenetic modification, playing an essential role in the silencing of repetitive DNA, in genomic imprinting and, in females, the establishment of X chromosome inactivation. There are 5 DNA metyhltransferases, and one of them, DNMT3B has an important role in de novo methylation. MeCP2, by its turn, is a protein capable of recognizing methylated DNA sites and of recruiting proteins responsible for histones deacetylation. This causes alterations in chromatin conformation, therefore inhibiting gene transcription. Changes in the expression patterns of DNMT3B and in DNA methylation are found in several types of tumors, and temporal expression of Dnmt3b and Mecp2 during global demetyhlation and de novo methylation waves, which occur in early embryonic development, could give a better understanding of the factors involved in the establishment and maintenance of DNA methylation patterns, which are still largely unkown. Additionally, a new class of small RNAs, the microRNAs, involved in the post-transcriptional gene silencing, has great importance in maintaining the differentiated state of several cell types. Recent studies have demonstrated alterations in miRNAs expression patterns between normal and tumor tissues. Thus, the aim of this work was to identify possible miRNAs involved in the modulation of Dnmt3b and Mecp2 RNAs in different normal and tumoral cell lines, as well as in human and murine embryonic stem cells and their respectively differentiated embryoid bodies.

La méthylation de l’ADN est une modification épigénétique qui prend place durant le développement embryonnaire sur le génome des Mammifères. Durant ma thèse, j’ai déterminé les cinétiques de mise en place de la méthylation de l’ADN sur le génome murin au cours de l’embryogénèse précoce. J’ai identifié les rôles spécifiques et redondants des ADN méthyltransférases DNMT3a et DNMT3b dans ce processus. J’ai également étudié le rôle de deux facteurs dans la mise en place de la méthylation de l’ADN dans l’embryon. Premièrement, j’ai déterminé que l’enzyme G9a joue un rôle essentiel pour la répression et le recrutement de la méthylation de l’ADN à des sites spécifiques du génome, incluant en particulier des promoteurs à ilots CpG de gènes méiotiques. Deuxièmement, l’étude du facteur E2F6 m’a permis de montrer que cette protéine est elle aussi impliquée dans le recrutement de la méthylation de l’ADN, et ce à des promoteurs de gènes méiotiques distincts de ceux régulés par G9a. / DNA methylation is an epigenetic modification which is established during embryonic development on the mammalian genome. In my thesis, I determined the kinetics of DNA methylation acquisition on the mouse genome during early embryogenesis, and determined the specific and redundant roles of the DNA methyltransferases DNMT3a and DNMT3b in this process. I also studied the roles of two factors involved in setting up DNA methylation in embryos. First, I determined that the G9a enzyme plays an essential role for the in vivo repression and DNA methylation of specific genomic sites, including in particular the CpG island promoters of germline genes. Second, the study of the E2F6 factor allowed me to show that this protein is also involved in recruiting DNA methylation at a set of germline gene promoters than are distinct from those regulated by G9a.

A metilação do DNA em mamíferos é uma importante modificação epigenética, sendo essencial no silenciamento de DNAs repetitivos, de regiões que sofrem imprinting genômico e no estabelecimento do cromossomo X inativo em fêmeas. Existem 5 tipos de DNA Metiltransferases, tendo a DNMT3B um importante papel na metilação de novo. A MeCP2, por sua vez, é uma proteína capaz de reconhecer sítios de DNA metilados e recrutar proteínas responsáveis pela desacetilação das histonas. Isto provoca alterações na conformação da cromatina, impedindo a transcrição gênica. Alterações nos padrões de expressão de DNMT3B e na metilação do DNA encontradas em diferentes tipos de tumores, e a temporalidade de expressão de Dnmt3b e de Mecp2 durante ondas de desmetilação e de metilação que ocorrem no início do desenvolvimento embrionário, podem auxiliar na identificação de fatores envolvidos no estabelecimento e manutenção do padrão de metilação do DNA, os quais ainda são pouco conhecidos. Por sua vez, uma nova classe de pequenos RNAs, os microRNAs, envolvidos com a regulação da expressão gênica pós-transcricional, têm grande importância na manutenção do estado diferenciado de diferentes tipos celulares. Trabalhos recentes demonstram também que há alterações nos padrões de expressão de microRNAs entre tecidos normais e tumorais. Assim, é objetivo deste trabalho a identificação de possíveis miRNAs envolvidos na modulação da expressão dos genes DNMT3B/Dnmt3b e MeCP2/Mecp2 em diferentes linhagens de células normais e tumorais, bem como, em células tronco embrionárias humanas e murinas submetidas à diferenciação. / DNA methylation in mammals is an important epigenetic modification, playing an essential role in the silencing of repetitive DNA, in genomic imprinting and, in females, the establishment of X chromosome inactivation. There are 5 DNA metyhltransferases, and one of them, DNMT3B has an important role in de novo methylation. MeCP2, by its turn, is a protein capable of recognizing methylated DNA sites and of recruiting proteins responsible for histones deacetylation. This causes alterations in chromatin conformation, therefore inhibiting gene transcription. Changes in the expression patterns of DNMT3B and in DNA methylation are found in several types of tumors, and temporal expression of Dnmt3b and Mecp2 during global demetyhlation and de novo methylation waves, which occur in early embryonic development, could give a better understanding of the factors involved in the establishment and maintenance of DNA methylation patterns, which are still largely unkown. Additionally, a new class of small RNAs, the microRNAs, involved in the post-transcriptional gene silencing, has great importance in maintaining the differentiated state of several cell types. Recent studies have demonstrated alterations in miRNAs expression patterns between normal and tumor tissues. Thus, the aim of this work was to identify possible miRNAs involved in the modulation of Dnmt3b and Mecp2 RNAs in different normal and tumoral cell lines, as well as in human and murine embryonic stem cells and their respectively differentiated embryoid bodies.

The field of epigenetics is gaining popularity and speed, due in part to its capability to answer lingering questions about the root cause of certain diseases. Epigenetics plays a crucial role in regulation of the cell and cell survival, particularly by cytosine methylation. It remains controversial if DNMT’s which facilitate methylation are present in mammalian mitochondria and what the functional significance they may have on modification of mitochondrial DNA. CRISPR-Cas9 technology enabled genome editing to remove the MTS (mitochondrial targeting sequence) from DNMT1 of HCT116 cells, purposefully minimizing effects on nuclear cytosine methylation, while exclusively impacting mitochondrial modification. Removal of the DNMT1 MTS did not completely prevent the localization of this enzyme to the mitochondria according to immunoblot analysis. As well, deletion of the MTS in DNMT1 revealed only a small decline in transcription; not until removal of DNMT3B did we see a two-fold decrease in transcription from mitochondrial protein coding genes. No significant decline in transcription occurred when a DNMT3B knockout also lost the MTS of DNMT1; this study is evidencing that DNMT3B is possibly the more significant methyltransferase in the mitochondria. Our aim from this study and future research is to clearly characterize which enzymes in the mitochondria are controlling cytosine modifications and to understand the mechanistic complexities that accompany cause and consequence of epigenetic modifications.

No description available.

<p>DNA methylation is an epigenetic modification that is nearly ubiquitous. Eukaryotic DNA methylation contributes to the regulation of gene expression and maintaining genome integrity. In mammals, DNA methylation occurs primarily on the C5 carbon of cytosine in a CpG dinucleotide context and is catalyzed by the DNA methyltransferases, DNMT1, DNMT3A and DNMT3B. While <i>dnmt3a</i> and <i>dnmt3b</i> genes are highly homologous, the enzymes have distinct functions. Some previous reports suggested differences in the enzymatic behavior of DNMT3A and 3B, which could affect their biological roles. The goal of my thesis work was to characterize kinetics mechanisms of DNMT3A and 3B, and to identify the similarities and differences in their catalytic properties that contribute to their distinct biological functions. Given the sequence similarity between the enzymes, we asked whether DNMT3B was kinetically similar to DNMT3A. In a series of experiments designed to distinguish between various kinetics mechanisms, we reported that unlike DNMT3A, DNMT3B methylated tandem CpG on DNA in a processive manner. We also reported that the disruption of the R-D interface, critical for the cooperativity of DNMT3A, had no effect on DNMT3B activity, supporting the non-cooperative mechanism of this enzyme. </p> <p>DNMT3A is frequently mutated in numerous cancers. Acute Myeloid Leukemia (AML) is a malignancy of hematopoietic stem cells in which numerous patients exhibit a high frequency of the heterozygous somatic mutation Arg882His in DNMT3A. Through thorough consensus motif building, we discovered a strong similarity in CpG flanking sequence preference between DNMT3A Arg882His variant and DNMT3B enzyme. Moreover, we found that the variant enzyme has the same kinetics mechanism as DNMT3B, indicating a gain-of-function effect caused by the mutation. This change is significant because the variant enzyme can aberrantly methylate DNMT3B targets in AML cells and effect global gene expression. In particular, given that DNMT3B has been shown to have oncogenic properties, this suggests that the Arg882His variant can acquire similar oncogenic properties and drive AML development.</p> <p>Taken together, my thesis work provides novel insights into the relationship between the biochemical properties and the biological functions of DNMT3A and 3B. </p>